Changing ethics rules land Spanish stem cell scientist in hot water
By Nature Medicine,
Nature Medicine
| 11. 29. 2005
The Spanish health ministry is considering legal action against one of the country's top stem cell scientists, saying he conducted research without proper authorization.
But the researcher, Carlos Sim¢n, and the local government in Valencia, where he works, say the ministry's actions are politically motivated.
Sim¢n, scientific director of the Valencian Infertility Institute, created two undifferentiated embryonic stem cell lines in March 2004. Two months later, along with former health minister Ana Pastor and Vicente Rambla, head of Valencia's health department, he publicly presented the lines.
He and his colleagues also published a full characterization of the lines in January (Fertil. Steril. 83, 246_249; 2005). He now says he has succeeded in differentiating them into cells resembling those in the pancreas, heart and brain.
But in late September, the central health ministry announced that the cell lines could no longer be used for research. Roberto Rodr¡guez, a spokesperson for the ministry, says Sim¢n did not have informed consent from parents for the 40 embryos he used for his research, nor did he have formal approval from the ministry. "That is...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...